DOI:
10.1055/s-00000181
Journal of Neurological Surgery Part B: Skull Base
LinksClose Window
References
Janku F, Wheler JJ, Naing A. , et al.
PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials.
Cancer Res 2013;
73 (01) 276-284
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.